Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Non Operating Income: 2010-2024

Historic Non Operating Income for OptimizeRx (OPRX) over the last 15 years, with FY2024 value amounting to -$5.7 million.

  • OptimizeRx's Non Operating Income rose 2741.12% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.1 million, marking a year-over-year increase of 850.15%. This contributed to the annual value of -$5.7 million for FY2024, which is 55872.37% down from last year.
  • Latest data reveals that OptimizeRx reported Non Operating Income of -$5.7 million as of FY2024, which was down 55872.37% from $1.2 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Non Operating Income ranged from a high of $1.2 million in FY2023 and a low of -$5.7 million during FY2024
  • For the 5-year period, OptimizeRx's Non Operating Income averaged around -$728706.2, with its median value being $16979.0 (2021).
  • Its Non Operating Income has fluctuated over the past 5 years, first surged by 491971.85% in 2022, then crashed by 55872.37% in 2024.
  • Annual analysis of 5 years shows OptimizeRx's Non Operating Income stood at -$71808.0 in 2020, then skyrocketed by 123.64% to $16979.0 in 2021, then skyrocketed by 4919.72% to $852298.0 in 2022, then skyrocketed by 45.25% to $1.2 million in 2023, then crashed by 558.72% to -$5.7 million in 2024.
  • Its Non Operating Income was -$5.7 million in FY2024, compared to $1.2 million in FY2023 and $852298.0 in FY2022.